Jonathan D Marotti

13PUBLICATIONS
39CO-AUTHORS
ClinimetricsPredictive and prognostic markersMolecular targetsPlanning and decision makingCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jun 22, 2026
Application of the International System for Serous Fluid Cytopathology in cerebrospinal fluid cytology: Overall survival analysis associated with diagnostic categories.

|Jan 08, 2025
Oxidative Phosphorylation Is a Metabolic Vulnerability of Endocrine Therapy-Tolerant Persister Cells in ER+ Breast Cancer.

Steven Tau, Mary D Chamberlin, Huijuan Yang

|Jul 13, 2023
Estrogen Therapy Induces Receptor-Dependent DNA Damage Enhanced by PARP Inhibition in ER+ Breast Cancer.

Nicole A Traphagen, Gary N Schwartz, Steven Tau

|Jun 28, 2023
Large-scale validation study of an improved semiautonomous urine cytology assessment tool: AutoParis-X.

Joshua J Levy, Natt Chan, Jonathan D Marotti

|Jun 26, 2023
Examining longitudinal markers of bladder cancer recurrence through a semiautonomous machine learning system for quantifying specimen atypia from urine cytology.

Joshua J Levy, Natt Chan, Jonathan D Marotti

|Jun 01, 2023
Alternating 17β-Estradiol and Aromatase Inhibitor Therapies Is Efficacious in Postmenopausal Women with Advanced Endocrine-Resistant ER+ Breast Cancer.

Gary N Schwartz, Peter A Kaufman, Karthik V Giridhar

Pageof 3

Frequent Collaborators

4 joint publications

Darcy A Kerr

3 joint publications

Edward J Gutmann

3 joint publications

Ryan E Glass

3 joint publications

Eugene Demidenko